Method and apparatus to control microbubble destruction during contrast-enhanced ultrasound imaging, and uses therefor

• US 6,858,011 B2
• Filed: 09/23/2002
• Issued: 02/22/2005
• Est. Priority Date: 09/21/2001
• Status: Active Grant

• Current Assignee: Trustees Of The University Of Pennsylvania (University of Pennsylvania)
• Original Assignee: Trustees Of The University Of Pennsylvania (University of Pennsylvania)
• Inventors: Sehgal, Chandra M.
• Primary Examiner(s): IMAM, ALI M
• Application Number:
  US10/252,642
• Publication Number:
  US 20030092991A1
• Time in Patent Office: 883 Days
• Field of Search: 600407-471, 424/9.51, 424/9.52, 424/9.53, 367/7, 367/11, 367/130, 367/138, 128/916, 73602-630
• US Class Current: 600/458
• CPC Class Codes: A61B 8/481 involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream analysis of echo signal exploiting properties of a contrast enhancer in devices for short-range imaging with acoustic waves G01S7/52039
• CPC Class Codes: A61B 8/543 involving acquisition triggered by a physiological signal

Abstract

Methods and apparatus are provided for controlling fluid flow or perfusion, wherein gas-filled microbubbles are used as ultrasound contrast-enhancing agents, and wherein the method comprises separating the removal of the contrast agent due to flow from the removal of the contrast agent due to bubble destruction for enhanced imaging processes. By varying exposure of the microbubbles to ultrasound, the method and apparatus apply the changes observed in the images to measure flow and vascularity, to improve visualization of blood flow and blood vessels, and to guide delivery of drugs locally to the site of imaging.

Claims

1. A quantitative method for enhanced ultrasound imaging of fluid flow or perfusion, wherein gas-filled microbubbles are used as ultrasound contrast-enhancing agents, and wherein the method comprises:

injecting at least one contrast agent that transits to the area or image plane to be imaged by ultra sound;

generating and transmitting a single-beam ultrasound gated pulse sequence to the image plane, wherein the gated imaging pulse sequence varies in repetition frequency (frame rates) under the control of a data acquisition controller means,

distinguishing removal of the contrast agent due to flow resulting from removal of the contrast agent due to bubble destruction for enhanced image processing;

thereby synchronizing and providing acquisition of multiple dilution curves per single injection of said contrast agent(s) resulting from the varied systematic and controlled exposing of the microbubbles to the ultrasound pulses, while maintaining the signal intensity of the pulse at less than high power intensity during transit of the contrast agent(s);

acquiring and digitizing images at each pulse; and

computing changes in image brightness as a function of time during transit of the at least one contrast agent, thereby detecting changes in microbubble concentration within the image plane, independent of flow direction or attenuation of signal by selection of the at least one contrast agent or material within the plane.

2. The method of claim 1, wherein the ultrasound imaging is selected from the group consisting of gray-scale imaging, harmonic imaging, and power Doppler imaging.

3. The method of claim 1, further comprising varying systematic and controlled destruction of the microbubbles by ultrasound pulses to enable physiological measurements of vascularity and blood flow.

4. The method of claim 1, wherein each dilution curve corresponds to a different exposure level.

5. The method of claim 4, further comprising detecting change(s) in the dilution curves produced by controlling time of exposure of the microbubbles in the contrast-enhancing agent to the ultrasound.

6. The method of claim 5, further comprising visualizing and recording the change(s) between or among the plurality of dilution curves.

7. The method of claim 5, further comprising using the change(s) in the dilution curves to provide an image guided drug delivery system in a patient, wherein controlled destruction of the at least one contrast enhancing agent permits controlled drug delivery in terms of time and location of delivery in the patient, wherein prior to administration to the patient the microbubbles are charged with a drug to be delivered to the patient.

8. The method of claim 4, further comprising using a single injection of the at least one contrast agent to obtain the plurality of dilution curves.

9. The method of claim 1, further comprising using the ultrasound in vitro or in vivo.

10. The method of claim 9, wherein the ultrasound is used in vivo to visualize blood flow and vasculature within organs, tissue or tumors in a patient'"'"'s body when the method is applied to the patient.

11. A device to provide quantitatively enhanced ultrasound images of fluid flow or perfusion using at least one ultrasound contrast agent comprising a plurality of gas-filled microbubbles, wherein the device comprises:

means for providing controlled flow of a fluid;

means for injecting at least one contrast agent into the fluid flow;

means for generating and transmitting a single-beam ultrasound gated pulse sequence to an image plane, wherein the gated imaging pulse sequence varies in repetition frequency (frame rates) under the control of a data acquisition controller means, to synchronize and provide acquisition of multiple dilution curves per single injection of said contrast agent(s) resulting from the varied systematic and controlled exposure of the microbubbles to the ultrasound pulses, but wherein the signal intensity of the pulse remains at less than high power intensity during transit of the contrast agent(s);

means to acquire and digitize images at each pulse; and

means to compute changes in image brightness as a function of time during transit of the at least one contrast agent, thereby detecting changes in microbubble concentration within the image plane, independent of flow direction or attenuation of signal by selection of the at least one contrast agent or material within the plane.

12. The device of claim 11, further comprising means for distinguishing removal of the at least one contrast agent due to flow resulting from removal of the contrast agent due to bubble destruction for enhanced image processing.

13. The device method of claim 12, wherein the ultrasound imaging is selected from the group consisting of gray-scale imaging, harmonic imaging, and power Doppler imaging.

14. The device of claim 11, further comprising means for varying systematic and controlled destruction of the microbubbles by ultrasound pulses to enable physiological measurements of vascularity and blood flow.

15. The device of claim 11, wherein each dilution curve corresponds to a different exposure level.

16. The device of claim 15, further comprising means for detecting change(s) in the dilution curves produced by controlling time of exposure of the microbubbles in the contrast-enhancing agent to the ultrasound.

17. The device of claim 16, further comprising means for visualizing and recording the change(s) between or among the plurality of dilution curves.

18. The device of claim 16, further comprising means for providing a controlled imaging system.

19. The device of claim 16, further comprising means for providing an image guided drug delivery system in a patient, wherein controlled destruction of the at least one contrast enhancing agent permits controlled drug delivery in terms of time and location of delivery in the patient, wherein prior to administration to the patient the microbubbles are charged with a drug to be delivered to the patient.

20. A device to measure fluid flow or perfusion using at least one ultrasound contrast agent comprising a plurality of gas-filled microbubbles, wherein the device comprises:

computer-readable signal bearing medium;

means in the medium for computing changes in image brightness as a function of time; and

means in the medium for algorithmically distinguishing the effect of removal of the at least one contrast agent due to flow from removal of the contrast agent due to bubble destruction.

21. The device of claim 20, further comprising means in the medium for automatically computing the blood flow in tissues by varying exposure of the ultrasound contrast agent(s) to imaging pulses.

22. The device of claim 21, wherein the ultrasound imaging is selected from the group consisting of gray-scale imaging, harmonic imaging, and power Doppler imaging.

23. The device of claim 20, further comprising means for varying systematic and controlled destruction of the microbubbles by ultrasound pulses to enable physiological measurements of vascularity and blood flow.

24. The device of claim 20, wherein each dilution curve corresponds to a different exposure level.

25. The device of claim 24, further comprising means for detecting change(s) in the dilution curves produced by controlling time of exposure of the microbubbles in the contrast-enhancing agent to the ultrasound.

26. The device of claim 25, further comprising means for visualizing and recording the change(s) between or among the plurality of dilution curves.

27. The device of claim 25, further comprising using the change(s) in the dilution curves to provide a controlled imaging system.

28. The device of claim 25, further comprising means for providing a controlled imaging system.

29. The device of claim 25, further comprising means for providing an image guided drug delivery system in a patient wherein the controlled destruction of the contrast enhancing agent permits controlled drug delivery in terms of time and location of delivery in the patient, wherein prior to administration to the patient the microbubbles are charged with a drug to be delivered to the patient.